Currently running — worth a closer look.
Running 47 days across 3 GEOs.
Seen across South Korea/QA/United States — the angle travels across these markets.
- Seen 47/30 days
- 3 GEOs
- Redirect chain checked
- LP host: precisionmedicineonline.com
Reverse-engineered from the live ad — longevity, GEOs, and the affiliate funnel behind it. Verified by following the redirect chain on Jun 10. Free, no login.
Funnel, reverse-engineered
The campaign behind this creative
← the actual path the money takes.
Creative
Precision Medicine Online | Sponsored
Landing page
precisionmedicineonline.com
where it lands
Product / Offer: not detected
Tracker: not detected
Affiliate network: not detected
How we know: the tracker and affiliate network come from the live redirect chain we followed and fingerprinted hop by hop. Greyed nodes weren’t detected.
Active
running 47d · last seen 6d ago · 3 markets
Running with a modest observed footprint so far.
Gravity
21/100
push pressure now · 30d index
Strength
32/100
overall scale · 30d index
Run
47d
last seen 6d ago
Markets
3
countries seen
Landing page
precisionmedicineonline.com
final host
Screenshot
—
not captured yet
Operator
—
unidentified
Network
Outbrain
traffic source
Four-Biomarker Blood Test Could Improve Early Pancreatic Cancer Detection
Precision Medicine Online | Sponsored@precision
Top 10% longevity in network
Days alive is a profitability proxy — advertisers don’t pay to run losers.
Geo reach
Broad multi-geo3 marketsPredominantly Tier 1, concentrated in APAC — South Korea, United States.
- Tier 12/3
- Tier 31/3
Regions:APAC 1MENA 1North America 1
What the data shows
Precision Medicine Online | Sponsored's Outbrain creative has been running for 47 days across 3 countries and first seen on April 24, 2026 and last seen on June 10, 2026. It has been observed in South Korea, QA, and United States. The ad lands on precisionmedicineonline.com. On our 30-day observation series the creative has cooled noticeably in the last week. Precision Medicine Online | Sponsored is running 8 other creatives we have indexed, linked below for side-by-side comparison.
Creative headline: Four-Biomarker Blood Test Could Improve Early Pancreatic Cancer Detection. Indexed on Outbrain by mediabuyer.
Landing-page intelligence
Landing page intelligence
Where this ad lands
The lander is the product — screenshot, redirect chain, offer, tech stack, and on-page text in one place.
Landing page not captured yet
Our crawler renders each advertiser’s funnel on a rolling schedule. Recently observed ads are queued first — check back to see the full-page screenshot.
Host
precisionmedicineonline.com
Path
/precision-oncology/four-biomarker-blood-test-could-improve-early-pancreatic-cancer-detection
Full URL
Redirect chain
Chain not captured yet.
Final host: precisionmedicineonline.com. Hop-by-hop capture runs as a separate pipeline; ads observed in recent ingests get crawled first.
Tracking parameters
- utm_source
- outbrain
- utm_medium
- paid content
- utm_campaign
- outbrain_labcorp-may25
- obOrigUrl
- true
+ 1 known tracker hidden (cloaker IDs scrubbed at ingest).
Tracking setup · Outbrain
Outbrain emits ob_click_id (your unique click), ob_source (publisher), ob_section (placement), and ob_position. Forward ob_click_id to your tracker as the postback key. ob_source and ob_section are the two highest-signal sub-IDs for blacklisting.
?ob_click_id={ob_click_id}&ob_source={ob_source}&ob_section={ob_section}&ob_position={ob_position}Default Outbrain setup template: ?ob_click_id={ob_click_id}&ob_source={ob_source}&ob_section={ob_section}&ob_position={ob_position}
Tech stack
No third-party monetization stack detected — this appears to be a direct landing page.
Landing page hubs
Landing page text
On-page text not extracted yet.
Observed daily (last 30 days)
Apr 25 → May 24·peaks May 15
30-day run pattern
FadingActivity has collapsed in the last week — the buyer is winding this creative down or rotating to a new variant.
- Coverage
- 3% of 30d
- Peak surge
- 1× vs median
- Last 7d
- 0
- WoW
- -100%
Peak day:
Window: Apr 25 → May 24
Sibling creatives from this campaign
Other creatives in Other on Outbrain
The rest of the set they’re running — see what else this angle is paired with.
Roche, BioNTech Advance Personalized mRNA Vaccine Bladder Cancer Trial
Genetic Testing Becoming Routine Care at More Places, but Reimbursement Hurdles Linger, UPMC Survey Finds
Researchers in Taiwan Suggest a New CA19-9 Threshold Could Identify High-Risk Pancreatic Cancer
MRD, MCED Most Promising Cancer Dx Technologies, According to Labcorp Oncologist Survey
Study Shows Feasibility of Offering MSK-IMPACT Test Internationally for Pediatric Cancer
FDA Rule Dead and Buried, Oncologists Navigate Complex Lab-Developed Test Landscape
Real-World Data Show Most Bladder Cancer Patients Getting Biomarker Testing in Community Network
DPYD Testing Before Chemo at Atrium Health Saves $37 per Patient, Leads to Fewer Hospitalizations
Tested headline variants8
Tested headline variants
Precision Medicine Online | Sponsored's own A/B test — which headline they kept
The advertiser’s own A/B result, handed over: ranked by days running, the survivor on top. Variants they stopped running are struck through — they tested and killed those angles.
- #1Real-World Data Show Most Bladder Cancer Patients Getting Biomarker Testing in Community NetworkKilled52d12 content tokens
- #2Study Shows Feasibility of Offering MSK-IMPACT Test Internationally for Pediatric CancerKilled50d10 content tokens
- #3MRD, MCED Most Promising Cancer Dx Technologies, According to Labcorp Oncologist SurveyKilled46d10 content tokens
- #4DPYD Testing Before Chemo at Atrium Health Saves $37 per Patient, Leads to Fewer HospitalizationsKilled41d13 content tokens
More from Precision Medicine Online | Sponsored8
More from Precision Medicine Online | Sponsored
Most spy tools stop at the creative. This page connects it to the campaign behind it — the funnel, the longevity, the GEOs. Free.